These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29504582)

  • 1. Hypercalcemia and hypercalciuria during denosumab treatment in children with osteogenesis imperfecta type VI.
    Trejo P; Rauch F; Ward L
    J Musculoskelet Neuronal Interact; 2018 Mar; 18(1):76-80. PubMed ID: 29504582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta-the First Prospective Comparative Study.
    Liu J; Lin X; Sun L; Zhang Q; Jiang Y; Wang O; Xing X; Xia W; Li M
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1827-1836. PubMed ID: 38198649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.
    Hoyer-Kuhn H; Rehberg M; Netzer C; Schoenau E; Semler O
    Orphanet J Rare Dis; 2019 Sep; 14(1):219. PubMed ID: 31533771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.
    Seale E; Molina MO; Carsen S; Sheffield H; Koujok K; Robinson ME; Feber J; Smit K; Page M; Walker S; Khan N; Konji VN; Rauch F; Ward LM
    Calcif Tissue Int; 2023 May; 112(5):613-620. PubMed ID: 36867194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis Imperfecta Type VI in Individuals from Northern Canada.
    Ward L; Bardai G; Moffatt P; Al-Jallad H; Trejo P; Glorieux FH; Rauch F
    Calcif Tissue Int; 2016 Jun; 98(6):566-72. PubMed ID: 26815784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Denosumab vs Zoledronic Acid in OI Adults: A Prospective, Open-Label, Randomized Study.
    Lin X; Hu J; Zhou B; Wang X; Zhang Q; Jiang Y; Wang O; Xia W; Xing X; Li M
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1873-1882. PubMed ID: 38181430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two years' experience with denosumab for children with osteogenesis imperfecta type VI.
    Hoyer-Kuhn H; Netzer C; Koerber F; Schoenau E; Semler O
    Orphanet J Rare Dis; 2014 Sep; 9():145. PubMed ID: 25257953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor From Bala and Dayal: "Safety and Efficacy of Denosumab in Children With Osteogenesis Imperfecta-The First Prospective Comparative Study".
    Bala A; Dayal D
    J Clin Endocrinol Metab; 2024 Sep; 109(10):e1971-e1972. PubMed ID: 38712435
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.
    Hoyer-Kuhn H; Franklin J; Allo G; Kron M; Netzer C; Eysel P; Hero B; Schoenau E; Semler O
    J Musculoskelet Neuronal Interact; 2016 Mar; 16(1):24-32. PubMed ID: 26944820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Denosumab for Osteoporosis in Three Female Patients with Osteogenesis Imperfecta.
    Uehara M; Nakamura Y; Takahashi J; Kamimura M; Ikegami S; Suzuki T; Uchiyama S; Yamaguchi T; Kosho T; Kato H
    Tohoku J Exp Med; 2017 Jun; 242(2):115-120. PubMed ID: 28626166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of atypical femoral fracture in a patient with osteogenesis imperfecta.
    Tan JY; Seow CJ
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings.
    Li G; Jin Y; Levine MAH; Hoyer-Kuhn H; Ward L; Adachi JD
    Acta Paediatr; 2018 Mar; 107(3):534-537. PubMed ID: 29154388
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBS as a Tool to Differentiate the Impact of Antiresorptives onCortical and Trabecular Bone in Children With OsteogenesisImperfecta.
    Rehberg M; Winzenrieth R; Hoyer-Kuhn H; Duran I; Schoenau E; Semler O
    J Clin Densitom; 2019; 22(2):229-235. PubMed ID: 30309730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab: an Emerging Therapy in Pediatric Bone Disorders.
    Boyce AM
    Curr Osteoporos Rep; 2017 Aug; 15(4):283-292. PubMed ID: 28643220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation.
    Andiran N; Alikasifoglu A; Gonc N; Ozon A; Kandemir N; Yordam N
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):63-72. PubMed ID: 18404974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Bone Mineral Density on Quality of Life in Patients with Osteogenesis Imperfecta during Treatment with Denosumab.
    Hoyer-Kuhn H; Stark C; Franklin J; Schoenau E; Semler O
    Pediatr Endocrinol Rev; 2017 Nov; 15(Suppl 1):123-129. PubMed ID: 29292876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.